UTMD Utah Medical Products Inc. Cumulative Company Assets

Official company branding of Utah Medical Products Inc. (UTMD)

This daily price chart on the GURU.Markets platform reflects the trend of total assets for Utah Medical Products (UTMD), which currently stand at 125.18. Utah Medical Products (UTMD) adheres to a policy of autonomous development, eschewing costly acquisitions in favor of organic growth. The company generates revenue through the sale of highly specialized equipment for neonatology and gynecology. Management follows a conservative financial model, striving to maximize returns for shareholders.

Company Total Assets: Utah Medical Products Inc. (UTMD) for 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for Utah Medical (UTMD)

- stock quotes and analyst forecast:
Share Price utahmed.com|UTMD - Price Target Chart
- market capitalization data:
Market Valuation Utah Med|UTMD - Enterprise Value
- company book value details:
Net Asset Value per Share Utah Medical Products|UTMD - Book Capitalization|Capitalization to Book Value Ratio utahmed.com|UTMD - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Utah Medical Products|UTMD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Utah Med|UTMD - Company Aggregate Debts|Debts to Book Capitalization Utah Med|UTMD - Company Long-Term Debt|Company Short-Term Debt Utah Medical Products|Intermediate Coverage Ratio utahmed.com
- company profitability and valuation multiples indicators:
UTMD - Net Profit
Fundamental valuation:Utah Medical Products
Mass-produced product of Utah Medical Products

This indicator is critical for stress-testing capital resilience and the primary screening of the issuer. The metric determines the total value of the company's resources, calculated inversely via ROA to capture the current market consensus. The current total asset volume has reached 125.18, reflecting the scale of the resource base. The stability of this line confirms the predictability of Utah Medical Products (UTMD) revenues due to its dominance in a niche medical instrumentation segment.

Main competitors

Total Business Assets ISRG|Aggregate Company Assets Danaher|Cumulative Company Assets BD (BDX)|Company Total Assets STE|WST - Company Assets|Company Total Assets BAX (Baxter International)|MASI: Total Business Assets|Stevanato Group - Company Total Assets|Company Total Asset Base Teleflex Inc. TFX|MMSI: Company Total Assets|Cumulative Company Assets Nobel Biocare|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets dentsplysirona.com|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets ATRC (AtriCure Inc)|STAAR Surgical Corp - Cumulative Company Assets|Aggregate Asset Value NAGE|ZimVie Inc. - Company Total Assets|Company Total Asset Base angiodynamics.com ANGO|Cerus (CERS) - Aggregate Company Assets|Total Business Assets TKNO|Aggregate Company Assets Monogram Technologies Inc|Sharps Tech (STSS) - Company Total Asset Base|Cumulative Company Assets INFU (InfuSystem Holdings)|Aggregate Business Assets KRMD|Aggregate Company Assets Nyxoah NYXH|Aggregate Asset Value MBOT|PDEX: Cumulative Company Assets|ZTEK - Company Total Assets|Elutia Inc. (ELUT) - Aggregate Company Assets|Cumulative Company Assets milestonescientific.com|NXGL (NEXGEL) - Company Total Assets|Company Assets Retractable Tech RVP|Aggregate Company Assets Harvard Bioscience (HBIO)|Femasys Corporation - Total Business Assets|Meihua Medical Technologies Co., Ltd. - Cumulative Company Assets|Aggregate Business Assets POAI (Predictive Oncology Inc)|CJMB - Aggregate Company Assets|Company Total Asset Base Atrion Corp. ATRI|NURO (NeuroMetrix Corp) - Cumulative Company Assets